Technology
A receptor discovery platform that translates food molecules into measurable metabolic outcomes.
The TruePath® Receptor Platform
An end-to-end discovery system for ligand interactions with chemosensory GPCRs.
TruePath is our platform for understanding how ligands interact with chemosensory GPCRs, including olfactory receptors (ORs) and taste receptors.
While these receptors enable smell and taste in the nose and tongue, they also occur throughout the body as ectopic receptors, where they participate in diverse biological processes—including regulation of glucose and lipid metabolism.
What TruePath enables:
- Identify ectopic receptor biology linked to high-value metabolic endpoints
- Determine which ligands activate or inhibit those receptors
- Build formulations anchored in a defined mechanism, not “ingredient storytelling”
Our Technology
Ectopic ORs regulate diverse metabolic processes like insulin and glucagon secretion, fatty acid metabolism, and thermogenesis. Deciphering their function and olfactory recognition code with specific ligands identifies ectopic ORs as potential targets for treating various diseases.
Olfactive Biosolutions has developed world-leading receptor technology and expertise in both olfactory and taste receptors in the nose and tongue, and ectopic receptors in the gut, lungs, skin, heart, blood and elsewhere.
Our Innovation
Mechanism-first formulation design using food-molecule ligands
Our technology characterizes what ectopic receptors do physiologically and which ligands activate or inhibit them.
Importantly, these ligands can often be food molecules humans have consumed for millennia—creating a scalable path to productization when paired with rigorous receptor validation.
Our standard: demonstrate a clear mechanism of action (MOA) for every formulation we make—so customers and partners can trust that Pivit formulations are based on valid and reliable science.